Bioactivity:

Evogliptin tartrate has potential for anti-atherosclerosis therapy that targets arterial inflammation.�Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.

CAS nr:

1222102-51-3

Purity:

98%

Molecular Weight:

551,51

SMILES:

O=C1NCCN(C(C[C@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@@H]1COC(C)(C)C.O=C(O)[C@H](O)[C@@H](O)C(O)=O

Formula:

C23H32F3N3O9

Pathway:

Proteases/Proteasome

Target:

DPP-4